Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1696
https://www.valueinhealthjournal.com/article/S1098-3015(14)03626-2/fulltext
Title :
Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03626-2&doi=10.1016/j.jval.2014.08.1696
First page :
A533
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1169